Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Periodontal Disease - Pipeline Assessment and Market Forecasts to
2017
Published on July 2010

Report Summary

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist's new report, 'Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017'
is an essential source of information and analysis on the global periodontal disease market. The report identifies the key trends
shaping and driving the global periodontal disease market. The report also provides insight on the prevalent competitive landscape
and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly,
the report provides valuable insight on the pipeline products within the global periodontal disease sector. The global periodontal
disease market was valued at $1,248m in 2009 and is characterized by efficacious dental procedures such as scaling, root planing
and surgery. The periodontal therapeutics market comprises Local Applied Antibodies (LAAs) and systemic applied antibodies. The
influx of new drugs and the increase in the uptake of LAAs will the drive the market in the forecast period. The various phases of the
developmental pipeline contain 19 molecules. Of these, only five are in Phase III and the rest are in the early stages of development.
The pipeline consists of no new antibiotics. The combinations of the tetracylines are expected to improve the efficacy of the treatment.
However, the drug is similar in nature to doxycyclines. The entry of cost effective drugs in the forecast period is expected to aid the
market growth.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house
analysis by GlobalData's team of industry experts.

Scope

- The report provides information on the key driver and challenges of the global periodontal disease market. Its Scope includes:
- Annualized global periodontal disease market revenues data from 2001 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The
key classes of mechanism of action include tetracycline antibiotics, osteoblast stimulators and anti-inflammatories, H+/K+ ATPase
inhibitors; cell wall synthesis inhibitors.
- Analysis of the current and future market competition in the global periodontal disease market. The key market players covered are
Kaken Pharmaceutical, Fibrocell Science, Inc., Tolmar Inc., Orapharma and Combinatorx, Inc.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a
qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future
periodontal disease market.

Reasons to buy

- The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by
identifying companies with the most robust pipeline.

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017 Page 1/6


- Develop business strategies by understanding the trends shaping and driving the global periodontal disease market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to
impact the global periodontal disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of
various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive
advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities
for consolidations, investments and strategic partnerships.
- What's the next big thing in the global periodontal disease market landscape' ' Identify, understand and capitalize.

Table of Content

1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Global Periodontal Disease: Market Characterization 4
2.1 Overview 4
2.1.1 Treatment Options 5
2.2 Periodontal Disease Market Size 6
2.3 Periodontal Disease Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Periodontal Disease Market 9
2.4.1 Drivers for the Periodontal Disease Market 9
2.4.2 Barriers for the Periodontal Disease Market 9
2.5 Opportunity and Unmet Need 10
2.6 Key Takeaway 11
3 Global Periodontal Disease Market: Competitive Assessment 12
3.1 Overview 12
3.2 Strategic Competitor Assessment 12
3.3 Product Profile for the Major Marketed Products in the Periodontal Disease Market 13
3.3.1 Periostat (Doxycycline Hyclate) 13
3.3.2 Arestin (minocycline hydrochloride microspheres) 14
3.3.3 Periochip (chlorhexidine gluconate) 15
3.3.4 Atridox (doxycycline hyclate 10%) 15
3.4 Key Takeaway 17
4 Global Periodontal Disease Market: Pipeline Assessment 18
4.1 Overview 18
4.2 Strategic Pipeline Assessment 18
4.3 Periodontal Disease Market ' Promising Drugs under Clinical Development 20
4.4 Molecule Profile for Promising Drugs under Clinical Development 20
4.4.1 Minocycline HCl 20
4.4.2 Trafermin (bFGF: Basic fibroblast growth factor) 20
4.5 Periodontal Disease Market ' Clinical Pipeline by Mechanism of Action 21
4.5.1 Periodontal Disease ' Phase III Clinical Pipeline 22
4.5.2 Periodontal Disease ' Phase II Clinical Pipeline 22
4.5.3 Periodontal Disease ' Phase I Clinical Pipeline 23
4.5.4 Periodontal Disease' Preclinical Pipeline 23
4.6 Key Takeaway 23



5 Global Periodontal Disease Market: Implications for Future Market Competition 24
6 Global Periodontal Disease Syndrome Market: Future Players 25
6.1 Introduction 25
6.2 Fibrocell Sciences, Inc 25
6.2.1 Company Overview 25
6.2.2 Business description 25
6.3 Orapharma 26
6.3.2 Business Description 26
6.4 Tolmar Inc 26
6.5 Kaken Pharmaceutical 27
6.5.1 Overview 27
6.6 Eli Lilly & Company 28
7 Periodontal disease Market: Appendix 30
7.1 Definitions 30
7.2 Scope of Pipeline Research 30
7.3 Acronyms 30
7.4 Research Methodology 31
7.4.1 Coverage 31
7.4.2 Secondary Research 31
7.4.3 Forecasting 32
7.4.4 Primary Research 35
7.4.5 Expert Panels 35
7.5 Contact Us 35
7.6 Disclaimer 35
7.7 Sources 36

1.1 List Of Tables
Table 1:Various Types of Medications Employed in Treating the Periodontal Disease 6
Table 2: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009 7
Table 3: Periodontal Disease, Global, Forecasted Reveune ($m), 2009-2016 8
Table 4: Major Marketed Products Comparison in Periodontal Disease Market, 2010 16
Table 5: Periodontal Disease ' Most Promising Drugs Under Clinical Development, 2010 20
Table 6: Periodontal Disease ' Phase III Clinical Pipeline, 2010 22
Table 7 Periodontal Disease' Phase II Clinical Pipeline, 2010 22
Table 8 Periodontal Disease ' Phase I Clinical Pipeline, 2010 23
Table 9: Periodontal Disease ' Preclinical Pipeline, 2010 23
Table 10: Fibrocell Sciences, Inc ' Periodontal disease Pipeline Product Portfolio, 2010 26
Table 11: Orapharma ' Periodontal Disease Pipeline Product Portfolio, 2010 26
Table 12: Tolmar, Inc - Periodontal Disease Pipeline Product Portfolio, 2010 27
Table 13: Kaken Pharmaceutical ' Periodontal Pipeline Product Portfolio, 2010 28
Table 14: Eli Lilly ' Periodontal Disease Pipeline Product Portfolio, 2010 29

1.2 List Of Figures
Figure 1: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009 7



Figure 2: Periodontal Disease, Global, Forecasted Revenue ($m), 2009-2017 8
Figure 3: Opportunity and Unmet Need in the Periodontal Disease Market, 2010 10
Figure 4: Strategic Competitor Assessment, 2010 13
Figure 5: Pipeline Products by Phase of Development, 2010 18
Figure 6: Technology Trends Analytics Frame Work, 2010 19
Figure 7: Technology Trends Analytics Frame Work ' Description, 2010 19
Figure 8: Periodontal Disease Market ' Clinical Pipeline by Mechanism of Action, 2010 21
Figure 9: Periodontal Disease Market ' Clinical Pipeline by Phase of Development, 2010 21
Figure 10: Implications for Future Market Competition in the Periodontal Disease Market, 2010 24
Figure 11: Periodontal Disease Market ' Clinical Pipeline by Company, 2010 25
Figure 12: GlobalData Methodology, 2010 31
Figure 13: GlobalData Market Forecasting Model, 2010 34

Companies mentioned
Fibrocell Sciences, Inc
Orapharma
Tolmar Inc
Kaken Pharmaceutical
Eli Lilly & Company



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 000.00 Quantity: _____

Site License--USD 4 000.00 Quantity: _____

Corporate License--USD 6 000.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Recommended

Recommended

More Related Content

More from ReportLinker.com

More from ReportLinker.com (20)

Recently uploaded

Recently uploaded (20)

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017